tiprankstipranks
Trending News
More News >
FibroBiologics, Inc. (FBLG)
NASDAQ:FBLG
US Market

FibroBiologics, Inc. (FBLG) Income Statement

Compare
78 Followers

FibroBiologics, Inc. Income Statement

Last quarter (Q3 2024), FibroBiologics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, FibroBiologics, Inc.'s net income was $-500.00K. See FibroBiologics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -437.00K$ -94.00K$ 0.00$ 0.00
Operating Expenses
$ 8.89M$ 4.37M$ 1.58M$ 1.17M
Depreciation and Amortization
$ 437.00K$ 94.00K$ 0.00$ 1.17M
EBITDA
$ -15.90M$ -4.37M$ -1.58M$ 0.00
Operating Income
$ -8.89M$ -4.47M$ -1.58M$ -1.17M
Other Income/Expenses
$ -7.60M$ -654.00K$ -4.00K$ 0.00
Pretax Income
$ -16.48M$ -5.12M$ -1.58M$ -1.17M
Net Income
$ -16.48M$ -5.12M$ -1.58M$ -1.17M
Per Share Metrics
Basic EPS
$ -0.59$ -0.16$ -0.05$ -0.13
Diluted EPS
$ -0.68$ -0.16$ -0.05$ -0.13
Weighted Average Shares Outstanding
32.49M 32.49M 32.49M 8.75M
Weighted Average Shares Outstanding (Diluted)
28.23M 32.49M 32.49M 8.75M
Currency in USD

FibroBiologics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis